Mineralys Therapeutics
MLYS
#6162
Rank
NZ$1.22 B
Marketcap
$24.57
Share price
-6.42%
Change (1 day)
14.49%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total debt

Total debt on the balance sheet as of December 2024 : N/A

According to Mineralys Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Mineralys Therapeutics - Total debt on balance sheet (in 2020)

Total debt by year

Year Total debt Change
2020-12-31NZ$6.23 M